Categories
Tags
Abbott Advertising AstraZeneca Barack Obama Big Pharma Biotechnology and Pharmaceuticals Bristol Myers Squibb business Cancer Clinical trial conference Deal Eli Lilly European Commission European Union Facebook FDA Food and Drug Administration Genentech generics GlaxoSmithKline Google GSK HBA Health Health care Johnson & Johnson layoffs Lilly Marketing Merck Novartis Pfizer Pharma Pharmaceutical drug pharmaceutical industry Research and development Roche Sanofi-Aventis Schering Plough social media Twitter U.S. Food and Drug Administration United States Wyeth
Technology News
BioPharm News
Category Archives: Sales
Merck to Axe 7,200 Positions
Not much in the way of good news at Merck this morning. The pharma giant announced that it is revising its financial guidelines through 2010, and eliminating 7,200 positions by 2011. The move is expected to save the company $3.8 billion to $4.2 billion through 2013.
The layoffs will be staggered throughout different parts of the [...]
Also posted in Strategy Tagged Gardasil, jobs, layoffs, Merck, Richard T. Clark, Vytorin, Zetia Leave a comment
The Truth About Closed-Loop Marketing
Pharma sales forces were out, well, in force for a two-day leadership summit put on by the Center for Business Intelligence this week in Philadelphia. As a newbie on the pharma reporting scene, I eagerly await these conference opportunities…especially the ones that deal with important sales management topics. This conference, in particular, presented sessions on [...]
Also posted in Marketing, Meetings Tagged AstraZeneca, AZ, Center for Business Intelligence, closed-loop promotion, conference, e-detailing, Marketing, Matt Pammer, sales force Leave a comment
Mark Stevens: God and the Sales Pitch
Mark Stevens is at it again. This time, the guy who informed you that Your Marketing Sucks (Crown Business) wants you to know that God Is a Salesman (Hachette Book Group USA/Center Street). And no, he’s not kidding.
Say what you will about his provocative titles—clearly, Stevens is doing something right. He’s the CEO of MSCO, [...]
AZ's David Snow Questions the Value of Education
Aren’t Pharm Exec readers lucky? Right now, we’re working on a report for our February issue that draws on a discussion by high-ranking sales executives in the industry. I don’t want to give away too much, but we put together an expert panel about the changing sales model, and there were more than a few [...]

Pfizer Acquires Generics, Branded Ophthalics